Deck Bio, a biotechnology company advancing multi-pMHC targeted T cell engagers for solid tumors, today presented new preclinical data for its lead program, DBXO-1, at the American Association for ...
Nomic Bio today announced a partnership with Broad Clinical Labs (BCL) to integrate the Nomic platform into its multi-omic workflows, reshaping how scalable, high-throughput proteomics is delivered.
AllAfrica on MSN
Data, Democracy, and Uganda's 2026 Elections
On May 12, President Yoweri Kaguta Museveni, 81, will take the oath of office once again, extending a presidency that has shaped Uganda's political landscape for four straight decades. His victory in ...
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
Travel + Leisure on MSN
This Italian City Is the Birthplace of Pizza—and Its Vibrant Streets Are a Feast for the Senses
Here’s everything you need to know about planning a trip to Naples, Italy.
Advanced genomic testing could help erase significant disparities in breast cancer survival rates between white and Black ...
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response ...
Bieberchella forever.
Queen Elizabeth swore by her low-heeled black Anello & Davide patent shoes, ordering new pairs every year for over five ...
TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apoptosis and Decreased Tumor Volume in ALK-EML4 Positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results